The Food and Drug Administration (FDA) has introduced new guidelines for COVID-19 vaccines, focusing on those at highest risk for severe complications. The updated strategy will maintain the ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The Trump administration released a more stringent set of guidelines for approving Covid-19 ... approval, FDA Commissioner Dr. Marty Makary and the agency’s new vaccines chief, Dr. Vinay Prasad ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to ...

Critics fear that U.S. Department of Health and Human Services chief RFK, Jr., known for his antivaccine views, has picked a ...

At the time of this writing, a new strain (NB.1.8.1) is rapidly spreading in other countries and in North America.

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned ...

Robert F. Kennedy Jr. announced a panel including vaccine skeptics, drawing criticism from public health leaders and misinformation watchdogs.

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...